ARTES Biotechnology has announced a collaboration with global pharmaceutical company, Boehringer Ingelheim Animal Health. ARTES Biotechnology specialises in recombinant protein production, process and vaccine development from microbial expression systems. ARTES’ expression system Hansenula polymorpha is the preferred technology for affordable mass vaccination and recommended by the World Health Organization (WHO) for these purposes. In combination with ARTES’ METAVAX® platform, this offers a new, unique and economical approach to low-cost mass production of safe and effective vaccines required in the veterinary field.
US – Governor Terry E. Branstad travelled to Sioux Center last week to attend the grand opening for one of three Boehringer Ingelheim Vetmedica, Inc. (BIVI) specialised vaccine research facilities.
BARCELONA, SPAIN - An important anniversary in the history of porcine circovirus type 2 (PCV2) has been marked at a special international pig veterinary satellite symposium held in Barcelona, Spain in June 2011 as part of the 6th International Symposium on Emerging and Re-emerging Pig Diseases.
4th Boehringer Ingelheim Expert Forum on Farm-Animal Well-Being
Read and download the posters.
Ingelheim, Germany, 20 September 2017 – The winners of the 2017 European PRRS Research Award have been announced at this year’s international swine veterinary assembly by Boehringer Ingelheim Animal Health.
Sow herd vaccination, i.e. against influenza and other viruses that can be transferred from the sow’s blood stream through the uterine blood supply thereby breaking through the uterine barrier: PRRS-virus, Circovirus, Parvovirus
Good body condition and fitness of the sow
Get the latest news on Swine Health Subscribe to our newsletter